Old Web
English
Sign In
Acemap
>
authorDetail
>
David D. Thompson
David D. Thompson
Pfizer
Osteoporosis
Internal medicine
Selective estrogen receptor modulator
Breast cancer
Lasofoxifene
2
Papers
178
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Breast Cancer Incidence in the Randomized PEARL Trial of Lasofoxifene in Postmenopausal Osteoporotic Women
2010
Journal of the National Cancer Institute
Andrea Z. LaCroix
Trevor J. Powles
C. Kent Osborne
Kevin Wolter
John R. Thompson
David D. Thompson
D. Craig-Allred
Róisín Armstrong
Steve Cummings
Richard Eastell
Kristine E. Ensrud
Paul E. Goss
Andrew George Lee
Patrick Neven
David M. Reid
Madelyn Curto
Slobodan Vukicevic
Show All
Source
Cite
Save
Citations (119)
A nonprostanoid EP4 receptor selective prostaglandin E2 agonist restores bone mass and strength in aged, ovariectomized rats.
2005
Journal of Bone and Mineral Research
Hua Zhu Ke
D. Todd Crawford
H. Qi
H.A. Simmons
Thomas A. Owen
Vishwas M. Paralkar
Mei Li
Bihong Lu
William A. Grasser
Kimberly O'keefe Cameron
Bruce Allen Lefker
Paul DaSilva-Jardine
Dennis O. Scott
Qing Zhang
Xiao Yan Tian
Webster S. S. Jee
Thomas A. Brown
David D. Thompson
Show All
Source
Cite
Save
Citations (59)
1